Preclinical studies have demonstrated that TMAO can induce apoptosis in various target cells, such as human aortic vascular smooth muscle cells, 158 pancreatic acinous cells, renal tubular epithelial cells, 159 human aortic endothelial cells, 160,161 and neurons, 119 contributing to the development and progression of cardiovascular, renal, neurological, and pancreatic diseases
Approximately 60% of patients who used combination therapy may suffer severe side effects, including autoimmune inflammation in the heart and the nervous system [14, 15]
University of Florida scientists have determined the glucagon-like peptide 1, or GLP-1, appetite-suppressing hormone systems found in the gut and brain act independently of each other to control eating
Our commitment to quality means this product is free from harsh chemicals
Drug interactions: No known significant interactions